Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

August 1, 2024

Conditions
HyperglycemiaHypoglycemiaCritical IllnessDiabetes Mellitus
Interventions
DEVICE

Continuous glucose monitoring

Continuous glucose monitoring involves a wearable device that measures glucose with a sensor that is inserted subcutaneously. The sensor transmits data to receiving device that displays the glucose values.

DEVICE

Point of care glucose monitoring

Point of care glucose monitoring involves use of an external device that can provide glucose readings at a patient's bedside. These devices require a small blood sample from venous, arterial, or capillary fingerstick blood. The blood sample is analyzed by the device and reports a glucose value within 5 minutes. This method of glucose monitoring is a mainstay and standard of care for most hospitals in the United States.

Trial Locations (1)

32608

North Florida/South Georgia Veterans Health System, Gainesville

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Malcom Randall VA Medical Center

FED